Improving patient selection for coagulopathy testing in the setting of acute ischemic stroke

Neurology

Volumn 57, Issue 7, 2001, Pages 1333-1335

  Bushnell, Cheryl D ^a,d   Siddiqi, Zaeem ^a   Goldstein, Larry B ^a,b,c  

^a DUKE UNIVERSITY   (United States)

^b Ctr for Clin Hlth Policy Research   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; TICLOPIDINE; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; HYPERCOAGULABILITY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; RISK FACTOR; STROKE;

EID: 0035833974     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.7.1333     Document Type: Article

References (10)

1. Diagnostic testing for coagulopathies in patients with ischemic stroke
2. Use of specialized coagulation testing in the evaluation of patients with acute ischemic stroke
3. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial
4. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): Standardization and quantitation of results
5. The hypercoagulable state: Who, how, and when to test and treat
6. Antiphospholipid antibodies and thrombosis. A consequence, coincidence, or cause?
7. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke
8. Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity
9. Anticardiolipin antibodies and their associations with cerebrovascular risk factors
10. Cerebral infarction in young adults: A practical approach